Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients

  • STATUS
    Recruiting
  • participants needed
    600
  • sponsor
    Metaxa Hospital
Send
Updated on 16 February 2024
See if I qualify
cancer
heparin
solid tumors

Summary

During MeTHOS study will be collected Real World Data the clinical practice regarding Thromboprophylaxis in high thrombotic risk solid tumors patients undergoing surgical and /or chemotherapeutical treatment, for one year following the protocol initiation date.

Specifically focus will be on the following:

  • Number of thrombotic events
  • Anti-thrombotic management dosage & duration
  • Any bleedings related to anticoagulation
  • Patients' adherence and compliance

Details
Condition Thrombosis, Thrombosis, Solid Cancer
Age 18years - 100years
Treatment Low Molecular Weight Heparin
Clinical Study IdentifierNCT04248348
SponsorMetaxa Hospital
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patients who were diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic and genitourinary) undergoing surgery
Age 18 years
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
Life expectancy >6 months
Signed informed consent

Exclusion Criteria

Patients who were not diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic and genitourinary) undergoing surgery
Age < 18 years
ECOG performance status >2
Life expectancy <6 months
Not signed informed consent
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

cancer
heparin
solid tumors

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.